The debate on antifibrinolytics in liver transplantation: always, never, or sometimes?
- PMID: 39332678
- PMCID: PMC11474311
- DOI: 10.1016/j.bjane.2024.844562
The debate on antifibrinolytics in liver transplantation: always, never, or sometimes?
Conflict of interest statement
Conflicts of interest The authors declare no conflicts of interest.
References
-
- Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transplantation. 2006;12:117–123. - PubMed
-
- Cardenas JC, Matijevic N, Baer LA, Holcomb JB, Cotton BA, Wade CE. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients. Shock. 2014;41:514–521. - PubMed
Publication types
LinkOut - more resources
Full Text Sources